Prevacus Inc., Announces the Addition of Randy Travis to its Advisory Board
June 26, 2017 09:01 ET
|
Prevacus, Inc.
TALLAHASSEE, Fla., June 26, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and...
Prevacus Announces the Addition of Key Individuals to its Sports Advisory Board
February 22, 2017 10:15 ET
|
Prevacus, Inc.
TALLAHASSEE, Fla., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and...
Prevacus Announces Appearance on Fox Business
February 15, 2017 08:00 ET
|
Prevacus, Inc.
TALLAHASSEE, Fla., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and...
Prevacus to Begin Phase 1 Clinical Studies of PRV-002 for the Treatment of Concussion
February 09, 2017 16:01 ET
|
Prevacus, Inc.
TALLAHASSEE, Fla., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion aka mild Traumatic Brain Injury (mTBI) and...